Desloratadine Tablet, Film Coated
Product Images NDC 68180-153
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Desloratadine (NDC 68180-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Img-1 (D0744218 E3f5 49fe A611 E83fa7840aaf 02)
Img-2 (D0744218 E3f5 49fe A611 E83fa7840aaf 03)
This is a description of Desloratadine Tablets USP, a medication used to treat allergy symptoms. Each film-coated tablet contains 5mg of desloratadine. The medication is manufactured by Lupin Limited in India for Lupin Pharmaceuticals in the United States. It is recommended to store the tablets at 25°C (77°F) and to dispense them in a child-resistant container. The usual dosage instructions can be found in the package insert.*
Img-3 (D0744218 E3f5 49fe A611 E83fa7840aaf 04)
The text provides information about Desloratadine tablets containing 5 mg of the active ingredient. It includes dosage instructions, storage conditions, and details about the manufacturer. The tablets are film-coated and come in a unit dose package. The packaging is child-resistant. The text also mentions a patient information leaflet that should be dispensed separately to each patient by the pharmacist.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.